Citation Impact

Citing Papers

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
2007 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)
1993
Plasticenta: First evidence of microplastics in human placenta
2020 Standout
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
2015 StandoutNobel
Parenteral Anticoagulants
2012 Standout
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
2001 Standout
Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis
1997
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
2007
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Relation between dissolution profiles and toxicity of cisplatin-loaded microspheres
2002 StandoutNobel
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
2006
PROLONGATION OF ALLOGRAFT SURVIVAL BY Nippostrongylus brasiliensis IS ASSOCIATED WITH DECREASED ALLOSPECIFIC CYTOTOXIC T LYMPHOCYTE ACTIVITY AND DEVELOPMENT OF T CYTOTOXIC CELL TYPE 2 CELLS1
2000
Sex Differences in Pharmacokinetics and Pharmacodynamics
2009
Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats
2006
Head and neck cancer
2008 Standout
Pharmacokinetic aspects of biotechnology products
2004
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
Mucosal immunity and vaccines
2005 Standout
The Placental Barrier: the Gate and the Fate in Drug Distribution
2018
Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding
1988
Glucocorticoid‐induced tumour necrosis factor receptor family‐related receptor signalling exacerbates hapten‐induced colitis by CD4+ T cells
2006 StandoutNobel
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Delivery of LMW Heparin via Surface Coated Chitosan/peg-Alginate Microspheres Prevents Thrombosis
2002
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Cd45rc- γδ+ T–Cell Infiltration Is Associated With Immunologic Unresponsiveness Induced by Prior Donor–Specific Blood Transfusion in Rat Hepatic Allografts
2001
Heparin Immobilized Chitosan - Poly Ethylene Glycol Interpenetrating Network: Antithrombogenicity
1995
Pentosan polysulfate‐induced thrombocytopenia and thrombosis
1994
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
2009 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Structured emulsion-based delivery systems: Controlling the digestion and release of lipophilic food components
2010 Standout
Immune Regulation by helminth parasites: cellular and molecular mechanisms
2003 Standout
Treatment of cardiac arrhythmias during pregnancy
1993
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Hydrogen sulphide and its therapeutic potential
2007 Standout
The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention
2010 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Mesoporous Materials for Drug Delivery
2007 Standout
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Polycystic ovary syndrome
2016 Standout
Designing dendrimers for biological applications
2005 Standout
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
2006 Standout
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Anatomical basis of tolerance and immunity to intestinal antigens
2003
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Suppressing spatiotemporal lasing instabilities with wave-chaotic microcavities
2018 Science
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid
1989 Standout
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
1997
Anthropogenic stresses on the world’s big rivers
2018 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Dextran prodrugs — structure and stability in relation to therapeutic activity
1989
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Sulfur in human nutrition and applications in medicine.
2002
Mechanism of action of paracetamol protective agents in mice in vivo
1984
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
Plastic and Human Health: A Micro Issue?
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Pharmacokinetic evaluation of polymeric carriers
1996
Heparin kinetics determined by three assay methods
1982
A critical evaluation of the principles governing the advantages of intra-arterial infusions
1974
Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
2002
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Hydrogels in drug delivery: Progress and challenges
2008 Standout
Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route
2004

Works of G Lévy being referenced

Pharmacokinetics of fetal and neonatal exposure to drugs.
1981
Effect of prevention of inorganic sulfate depletion on the pharmacokinetics of acetaminophen in rats.
1986
Pharmacokinetics of heparin. I. Studies of dose dependence in rats.
1979
Kinetics of drug action in disease states. XXIX. Effect of experimental nephrotic syndrome on the pharmacodynamics of heptabarbital: implications of severe hypoalbuminemia.
1989
Pharmacokinetics of Metformin Gastric‐Retentive Tablets in Healthy Volunteers
2001
A ROLE FOR ????TCR+ CELLS IN REGULATION OF REJECTION OF SMALL INTESTINAL ALLOGRAFTS IN RATS1
1996
Pharmacologic target-mediated drug disposition
1994
Targeted Drug Delivery-Some Pharmacokinetic Considerations
1987
Rapid Development of Functional Tolerance to Caffeine-Induced Seizures in Rats
1988
Chaotic effects in flared lasers: a numerical analysis
1997
Intersubject variation of warfarin binding to protein in serum of normal subjects.
1976
Pharmacokinetics of Drug Action
1972
Protein Binding of Bilirubin in Plasma of Anephric Patients
1980
[Multiple arterial and venous thromboses associated with thrombopenia. Role of pentosan polysulfate and heparins].
1986
Sulfate conjugation in drug metabolism: role of inorganic sulfate.
1986
Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.
1981
Pharmacokinetics of heparin. II. Studies of time dependence in rats.
1979
Rankless by CCL
2026